Of the 510 HNSCC patients in the TCGA cohort, 98 (19.22%) had gene mutations, with the highest frequency of MYH9 mutations (5%), followed by FLNA, MYH10and TLN1(Fig. 1A). This evidence concerns the gene FLNA and head and neck squamous cell carcinoma.